Found 50 clinical trials
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Psychiatry/Psychology
-
Currently Recruiting
[ONLINE] Dementia dogs: Their impact on community-dwelling persons with mild to moderate dementia
This study is looking for pairs of participants: a person with mild-to-moderate dementia, and their caregiver. The study is interested in the difference that dogs can make in
- 20 views
- 12 Oct, 2020
- 251 locations
-
Phase 3 trial
-
Accepting Seniors
-
Accepting adults
-
Currently Recruiting
Patients with Mild-Moderate Alzheimer's Disease
Patients with Mild-Moderate Alzheimer's Disease
- 90 views
- 08 Dec, 2020
- 1 location
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Psychiatry/Psychology
-
Currently Recruiting
Non-Immersive Virtual Reality as a Cognitive Rehabilitation
The study is looking for people over 65 who have mild-to-moderate dementia. The study is testing a computer game.
- 12 views
- 15 Sep, 2020
- 1 location
-
Phase 2 trial
-
Accepting pediatric ages
-
Accepting adults
-
Currently Recruiting
A Randomized, 18-Week, Placebo-Controlled, Double-Blind, Parallel Group Study Of The Safety And Efficacy Of PF-05212377 (SAM-760) In Subjects With Mild-To-Moderate Alzheimer's Disease With Existing Neuropsychiatric Symptoms On A Stable Daily Dose Of Donepezil
A Randomized, 18-Week, Placebo-Controlled, Double-Blind, Parallel Group Study Of The Safety And Efficacy Of PF-05212377 (SAM-760) In Subjects With Mild-To-Moderate Alzheimer's Disease With Existing
- 62 views
- 08 Dec, 2020
- 1 location
-
Phase 3 trial
-
Accepting Seniors
-
Accepting adults
-
Currently Recruiting
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease
- 106 views
- 08 Dec, 2020
- 1 location
-
Phase 2 trial
-
Accepting Seniors
-
Accepting adults
-
Currently Recruiting
A clinical research study to evaluate the added benefit of an investigational drug in people with moderate Alzheimer’s disease who are currently taking stable doses of Donepezil and either Memantine or Namenda XR.
A clinical research study to evaluate the added benefit of an investigational drug in people with moderate Alzheimer’s disease who are currently taking stable doses of Donepezil and either Memantine or Namenda XR.
- 204 views
- 08 Dec, 2020
- 1 location
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Currently Recruiting
Memory loss? Confusion? Difficulty completing familiar tasks? It may be Alzheimer's Disease.
Memory loss? Confusion? Difficulty completing familiar tasks? It may be Alzheimer's Disease.
- 114 views
- 08 Dec, 2020
- 1 location
-
Phase 3 trial
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An interventional trial
-
For all genders
-
Family Medicine
-
Currently Recruiting
Octohydroaminoacridine Succinate Tablet for Mild-to-Moderate Alzheimer's Disease
clinical trial to investigate the effects of octohydroaminoacridine in patients with mild-to-moderate Alzheimer's disease. Patients were randomized to receive placebo thrice daily, or
- 144 views
- 08 Nov, 2020
- 1 location
-
Phase 3 trial
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An interventional trial
-
For all genders
-
Family Medicine
-
Currently Recruiting
A Multinational Multi-center Randomized Double-blind Active Comparator Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients With Alzheimer's Disease
The objective of this study is to evaluate the efficacy and safety of donepezil transdermal patch in patients with mild to moderate Alzheimer's disease. The primary objective is to
- 784 views
- 08 Nov, 2020
- 1 location
-
Phase 2 trial
-
Accepting Seniors
-
Accepting adults
-
10s of participants
-
An interventional trial
-
For all genders
-
Family Medicine
-
Currently Recruiting
Open-label PK and Safety Study in Mild-to-moderate Alzheimer's Disease Patients
This is a Phase 2a, multi-center, open-label study of PTI-125 in mild-to-moderate AD patients, 50-85 years of age. A total of twelve (12) patients will be enrolled into the study. Patients will
- 49 views
- 08 Nov, 2020
- 2 locations